Human papillomavirus (HPV) vaccines

Show simple item record Visser, Adele Hoosen, Anwar Ahmed 2012-12-12T11:33:05Z 2012-12-12T11:33:05Z 2012-01
dc.description.abstract Human papillomavirus (HPV) infection has been estimated to cause 270 000 deaths worldwide annually from cervical cancer and approximately 80% of these occur in resource-poor countries.1 In South Africa, cervical cancer is the second most common malignancy among women, with the highest rate among black women aged 66 - 69 years.2 With the development of prophylactic HPV vaccines there are prospects of significant reduction in morbidity and mortality due to HPV infection and its complications. en_US
dc.description.uri en_US
dc.identifier.citation Visser, A & Hoosen, A 2012, 'Human papillomavirus (HPV) vaccines', CME : Continuing Medical Education, vol. 30, no. 1, pp. 29. en_US
dc.identifier.issn 1016-6742 (print)
dc.identifier.issn 2078-5143 (online)
dc.language.iso en en_US
dc.publisher Health and Medical Publishing Group en_US
dc.rights Health and Medical Publishing Group en_US
dc.subject Human papillomavirus (HPV) vaccines en_US
dc.title Human papillomavirus (HPV) vaccines en_US
dc.type Article en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record